La larga espera por la cura de la diabetes
Un documental recoge la desesperación y la frustración de los pacientes de diabetes de tipo 1 que participan en un ensayo clínico.
Un documental recoge la desesperación y la frustración de los pacientes de diabetes de tipo 1 que participan en un ensayo clínico.
America is determining the shape of health care affordability into the future.
Starting in 2025, Medicare recipients with prescription drug coverage will not have to pay more than $2,000 annually for medications, a significant savings for some.
A documentary captures the desperation and frustration of Type 1 diabetes patients in a clinical trial.
House progressives are calling on leadership to include people without health insurance in any legislation that limits out-of-pocket costs for insulin. Senate Democrats are pushing […]
A half-teaspoon a day of brewer’s yeast is put to the test in a randomized, double-blind, controlled clinical trial. In 1854, a case report was […]
California Gov. Gavin Newsom (D) announced on Thursday that his state will be producing its own “low cost” insulin, stating, “People should not go into […]
The natural plant-based sweeteners stevia and monk fruit (Luo Han Guo) are pitted head-to-head against aspartame and Splenda. A number of artificial sweeteners have been […]
Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets. Health2Sync […]
Sen. Raphael Warnock (D-Ga.) is pressuring Senate Majority Leader Charles Schumer (D-N.Y.) to hold a vote on legislation to lower the cost of insulin. Warnock […]
Arkansas has become the latest US state to issue a legal challenge to the big three insulin producers – Eli Lilly, Sanofi and Novo Nordisk […]
For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying […]
The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. […]
Mark Clements, MD, PhD, CPI, FAAP, Chief Medical Officer, Glooko, Inc. If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding […]
The bill stands to benefit millions of Americans with diabetes, but to become law, it will need to attract at least 10 Republican votes in […]
The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the monthly cost of insulin to patients that […]
Civica Rx plans to make lower cost versions of three branded insulin products, biosimilars that are expected to reach the market in 2024. In addition […]
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling […]
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can […]
President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.
President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease.
Novo Nordisk has said that the introduction of value-based procurement (VBP) for insulin products by the Chinese government will have an impact on its revenues […]
Perhaps surprisingly, the answer is PBMs, not drug manufacturers. That is one of the conclusions discussed in a recent commentary by Good and Hernandez (2021). […]
Not all drugs will be subject to price negotiation under the revised legislation. But the agreement sets up a framework enabling Medicare to negotiate the […]
Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the […]
Walmart struck a deal with Novo Nordisk to offer a heavily discounted, private-label version of its fast-acting analog insulin. But it still doesn’t solve the […]
NHS England will provide artificial pancreas devices to 1,000 type 1 diabetes patients as part of a pilot study of the technology, according to chief […]
UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other […]
What We Should Know: – Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a […]
What You Should Know: – Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. – […]
What You Should Know: – Medtronic has announced the launch of the world’s first and only infusion set that can be worn for up to […]
What You Should Know: – Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today […]
Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program […]
Athar Siddiqui: Global Strategy Lead, Digital Connected Solutions – Ascensia Diabetes Care “Information technology and business are becoming inextricably interwoven. I don’t think anybody can […]
Bryan Lubel, Executive Vice President, Connected Health of KORE Not many will disagree that the global pandemic has accelerated the use of technology in healthcare. […]
There are so many açaí products on the market now, from frozen pulp in smoothie packs to freeze-dried powder and supplements. How is it eaten […]
What You Should Know: – Today, Blue Cross and Blue Shield of North Carolina partners with Carrot Inc. and Virta Health to help address two […]
Given the role that oxidant free radicals are thought to play in aging and disease, one reason fruits and vegetables may be so good for […]
What You Should Know: – Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. – […]
Date: October 19, 2020 Issue #: 1609 Summary: The FDA has approved insulin lispro-aabc (Lyumjev – Lilly), a faster-acting formulation of insulin lispro (Humalog), for […]
What You Should Know: – Today, Medtronic announced that it will acquire Companion Medical, the manufacturer of InPen, a smart insulin pen system paired with an integrated […]
What You Should Know: – DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center […]
Whole plant sources of sugar and fat can ameliorate some of the postprandial (after meal) inflammation caused by the consumption of refined carbohydrates and meat. […]
Within hours of eating an unhealthy meal, we can get a spike in inflammation, crippling our artery function, thickening our blood, and causing a fight-or-flight […]
What’s more important: probiotics or prebiotics? And where can we best get them? “Virtually every day we are all confronted with the activity of our […]
Type 1 diabetes “arises following the autoimmune destruction of the insulin-producing pancreatic β [beta] cells…[and] is most often diagnosed in children and adolescents, usually presenting […]
Copyright © 2024 | WordPress Theme by MH Themes